Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study

This publication has 39 references indexed in Scilit:

• Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
  Diabetes, 2011
• GLP‐1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice
  Diabetes, Obesity and Metabolism, 2011
• Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
  Diabetes Care, 2010
• Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes
  Diabetes Care, 2010
• GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons
  Cardiovascular Research, 2010
• Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
  Diabetes Care, 2010
• Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
• Insulin Glargine
  Heart Disease, 2003
• Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial
  Annals of Neurology, 1995
• Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes
  Journal of Diabetic Complications, 1991